Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 22, 2010 - Issue 10
89
Views
2
CrossRef citations to date
0
Altmetric
Research Article

A 13-week nose-only inhalation toxicity study for perfluoro-n-butyl iodide (PFBI) in rats with recommended occupational exposure levels

, , , , &
Pages 847-860 | Received 02 Mar 2010, Accepted 18 Apr 2010, Published online: 27 May 2010

References

  • 49 CFR 173.133. (Amended 29 Dec 2006). Part 173 Shippers general requirements for shipments and packaging. Section 173.133 Assignment of packing group and hazard zones for Division 6.1 materials. http://edocket.access.gpo.gov/cfr_2007/octqtr/pdf/49cfr173.133.pdf
  • Armitage P. 1971. Statistical Methods in Medical Research. Oxford, UK: Blackwell Scientific Publications.
  • Bartlett MS. 1937. Properties of sufficiency and statistical tests. Proceedings of the Royal Society Series A. 160:268–282.
  • Capen CC. 1994. Mechanisms of chemical injury of thyroid gland. In: Receptor-Mediated Biological Processes: Implications for Evaluating Carcinogenesis. Spitzer HL, Slaga TJ, Greenlee WF and McClain M, eds. New York, NY: Wiley-Liss. 173–191.
  • Clewell H and Lawrence G. 1999. Position paper for trifluoroiodomethane (CF3I). ICF Incorporated Report prepared for U.S. EPA, 19 pages, http://www.concentric.net/∼cf3i/pospaper/posp.htm
  • Cochran WG and Cox GM. 1959. Experimental Designs, New York: John Wiley.
  • Dodd D, Hoffman G, Hardy C. 2004. Perfluoro-n-butyl iodide: acute toxicity, subchronic toxicity and genotoxicity evaluations. Int J Toxicol 23:249–258.
  • Dodd DE, Ledbetter AD and Mitchell AD. 1997a. Genotoxicity testing of the halon replacement candidates trifluoroiodomethane (CF3I) and 1,1,1,2,3,3,3-heptafluoropropane (HFC-227ea) using the Salmonella typhi-murium and L5178Y mouse lymphoma mutation assays and the mouse micronucleus test. Inhal Toxicol. 9:111–131.
  • Dodd DE, Kinkead ER, Wolfe RE, Leahy HF, English JH, Vinegar A. 1997. Acute and subchronic inhalation studies on trifluoroiodomethane vapor in Fischer 344 rats. Fundam Appl Toxicol 35:64–77.
  • Dodd DE, Leahy HF, Feldmann ML, English JH, Vinegar A. 1999. Reproductive toxicity screen of trifluoroiodomethane (CF(3)I) in Sprague-Dawley rats. Inhal Toxicol 11:1041–1055.
  • Dodd DE, Vinegar A. 1998. Cardiac sensitization testing of the halon replacement candidates trifluoroiodomethane (CF3I) and 1,1,2,2,3,3,3-heptafluoro-1-iodopropane (C3F7I). Drug Chem Toxicol 21:137–149.
  • Dunnett CW. 1955. A multiple comparison procedure for comparing several treatments with a control. J Am Stat Assoc 50:1096–1121.
  • Dunnett CW. 1964. New tables for multiple comparisons with a control. Biometrics, 20:482–491.
  • Gargas ML, Burgess RJ, Voisard DE, Cason GH, Andersen ME. 1989. Partition coefficients of low-molecular-weight volatile chemicals in various liquids and tissues. Toxicol Appl Pharmacol 98:87–99.
  • Gearhart JM, Mahle DA, Greene RJ, Seckel CS, Flemming CD, Fisher JW, Clewell HJ 3rd. 1993. Variability of physiologically based pharmacokinetic (PBPK) model parameters and their effects on PBPK model predictions in a risk assessment for perchloroethylene (PCE). Toxicol Lett 68:131–144.
  • Glass S, McCullough E, Dhooge P, Olson K and Nimitz J. 1999. Development of nonflammable, environmentally compliant fluoroiodocarbon (FIC) solvents. Air Force Research Laboratory, Materials and Manufacturing Directorate, Wright-Patterson AFB, OH. AFRL-ML-WP-TR-1999–4043.
  • Grubbs F. 1969. Procedures for detecting outlying observations in samples. Technometrics 11:1–21.
  • Kruskal WH and Wallis WA. 1952. Use of ranks in one-criterion variance analysis. J Am Stat Assoc 47:583–621.
  • Kruskal, W. H. and Wallis, W. A. 1953. Errata for Kruskal-Wallis 1952. J Am Stat Assoc, 48, 907–911.
  • ManTech Environmental Technology, Inc. 1994. Acute Inhalation Toxicity Study of Iodotrifluoromethane in Rats, Final Report Project No. 1530-001, 31 pages.
  • Meyer OA, Tilson HA, Byrd WC, Riley MT. 1979. A method for the routine assessment of fore- and hindlimb grip strength of rats and mice. Neurobehav Toxicol 1:233–236.
  • Moser VC. 1989. Screening approaches to neurotoxicity: a functional observational battery. J Amer Coll Toxicol 8:85–94.
  • National Research Council (NRC). 1996. Guide for the Care and Use of Laboratory Animals, Washington D.C.: National Academy Press.
  • National Research Council (NRC). 2005. Health Implications of Perchlorate Ingestion. Washington, D.C.: National Academies Press.
  • Organization for Economic Cooperation and Development. 1981a. OECD Guidelines for Testing of Chemicals, Part 403: Acute Inhalation. (August).
  • Organization for Economic Cooperation and Development. 1981b. OECD Guidelines for Testing of Chemicals, Part 412: Repeated Dose Inhalation Toxicity. (12 May).
  • Organization for Economic Cooperation and Development. 1981c. OECD Principles of Good Laboratory Practices [C(81)30 (Final) Annex 2].
  • Organization for Economic Cooperation and Development. 1983a. OECD Guidelines for Testing of Chemicals, No. 471: Genetic Toxicology: Salmonella typhimurium, Reverse Mutation Assay. (26 May).
  • Organization for Economic Cooperation and Development. 1983b. OECD Guidelines for Testing of Chemicals, No. 472: Genetic Toxicology: Escherichia coli, Reverse Mutation Assay. (26 May).
  • Organization for Economic Cooperation and Development. 1983c. OECD Guidelines for Testing of Chemicals, No. 473: Genetic Toxicology: In Vitro Mammalian Cytogenetic Test. (26 May).
  • Organization for Economic Cooperation and Development. 1992. OECD Environment Monograph, No. 45.
  • Roberts MB, Gschwender LJ and Snyder CE. 2003. The Wipe Solvent Program: Fluids, Lubricants, and Related Materials. Air Force Research Laboratory, Materials and Manufacturing Directorate, Wright-Patterson AFB, OH, AFRL-ML-WP-TR-2003–4040.
  • Rosner B. 1990. Fundamentals of Biostatistics. Boston, MA: PWS-Kent.
  • Schulze GE. 1990. Large-scale assessment of motor activity in rodents: procedures for routine use in toxicology studies. J Amer Coll Toxicol 9:455–463.
  • Shirley E. 1977. A non-parametric equivalent of Williams’ test for contrasting increasing dose levels of a treatment. Biometrics 33:386–389.
  • Siglin JC, Mattie DR, Dodd DE, Hildebrandt PK, Baker WH. 2000. A 90-day drinking water toxicity study in rats of the environmental contaminant ammonium perchlorate. Toxicol Sci 57:61–74.
  • Skaggs SR and Rubenstein R. 1999. Setting the occupational exposure limit for CF3I. In: Proceedings Halon Options Technical Working Conference 1999, Albuquerque, NM: The University of New Mexico, 254–261.
  • Snyder R, Bakshi KS and Wagner BM. 1997. Abstracts of the workshop on toxicity of alternatives to chlorofluorocarbons. Inhal Toxicol 9:775–810.
  • Sokal RR and Rohlf FJ. 1995. Biometry. 3rd Edition. San Francisco, CA: W.H. Freeman.
  • Steel RGD. 1959. A multiple comparison rank sum test: treatments versus control. Biometrics 15:560–572.
  • U.S. EPA. 1987. The Risk Assessment Guidelines of 1986. Office of Health and Environmental Assessment, Washington, DC. EPA/600/8-87/045
  • U.S. EPA. 1994. Methods for Derivation of Inhalation Reference Concentrations and Application of Inhalation Dosimetry. Office of Research and Development, Washington, D.C. EPA/600/8-90/066F
  • U.S. EPA. 1998. Health Effects Testing Guidelines OPPTS 870.1000 Acute Toxicity Testing – Background. Office of Prevention, Pesticides and Toxic Substances, U.S. Environmental Protection Agency, Washington D.C. EPA 712-C-98–189. http://www.epa.gov/opptsfrs/publications/OPPTS_Harmonized/870_Health_Effects_Test_Guidelines/Series/870–1000.pdf
  • U.S. EPA. 2002. A Review of the Reference Dose and Reference Concentration Processes. Risk Assessment Forum, Office of Research and Development, Washington, D.C. EPA/630/P-02/002F
  • U.S. EPA. (Updated 19 Oct 2009). Significant New Alternatives Policy (SNAP) Final Rule Summary. http://www.epa.gov/Ozone/snap/fact.html
  • UNEP. 2006. Handbook for the Montreal Protocol on Substances that Deplete the Ozone Layer. Seventh edition. Nairobi, Kenya: United Nations Environment Programme. http://ozone.unep.org/Publications/MP_Handbook/index.shtml
  • Weingand K, Brown G, Hall R, Davies D, Gossett K, Neptun D, Waner T, Matsuzawa T, Salemink P, Froelke W, Provost JP, Dal NG, Batchelor J, Nomura M, Groetsch H, Boink A, Kimball J, Woodman D, York M, Fabianson-Johnson E, Lupart M and Melloni E. 1996. Harmonization of animal clinical pathology testing in toxicity and safety studies. The Joint Scientific Committee for International Harmonization of Clinical Pathology Testing. Fundam Appl Toxicol 29:198–201.
  • Williams DA. 1971. A test for differences between treatment means when several dose levels are compared with a zero dose control. Biometrics 27:103–117.
  • Williams DA. 1972. The comparison of several dose levels with a zero dose control. Biometrics 28:519–531.
  • Williams RJ, Creech JR, Black RK, Neurath SK and Jepson GW. 1994. Gas uptake of bromotrifluoromethane (Halon 1301) and its proposed replacement iodotrifluoromethane (CF3I). Armstrong Laboratory, Toxicology Division, Wright-Patterson AFB, OH.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.